double exposure of success smart medical doctor working with abstract blurry bokeh  backgr

BOND3 Study

Clinicaltrials.gov ID:

CG Oncology Study ID:

CG3002S

Condition:

Non-Muscle Invasive Bladder Cancer

A Study of Intravesical CG0070 for Treatment of Patients with Non-Muscle Invasive Bladder Cancer (NMIBC)

The BOND3 study is testing an investigational drug called CG0070 for adults with non-muscle invasive bladder cancer (NMIBC) who have already tried BCG treatment. CG0070 is a type of immunotherapy, which is different from chemotherapy. Immunotherapy is a type of cancer treatment that helps your immune system fight cancer.


In this study, CG0070 will be given intravesically, meaning it is put directly into the bladder using a catheter (a thin tube put into your bladder). Throughout the study doctors will monitor your health and how your cancer is responding to the treatment.